Idaho will recover nearly $420,000 from an Indian generic drug manufacturer who admitted selling drugs of inferior strength, purity or quality in the United States, including through Idaho's Medicaid program.

 It's part of a $350 million national settlement between the federal government, the states and the company, which also pleaded guilty to seven felony counts and will pay $150 million in criminal fines and forfeitures.

“Taxpayers expect their tax dollars to be used to pay for a legitimate service,” Idaho Attorney General Lawrence Wasden said. “This settlement reflects our resolve to address losses to the Idaho Medicaid program caused by individuals and companies.” Read more. Betsy Russell, EOB

Thoughts?

---

---